Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden

BACKGROUND: The tumor immune environment not only modulates the effects of immunotherapy, but also the effects of other anticancer drugs and treatment outcomes. These immune responses can be evaluated with tumor-infiltrating lymphocytes (TILs), which has frequently been verified clinically. On the o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Asano, Yuka, Kashiwagi, Shinichiro, Goto, Wataru, Takada, Koji, Takahashi, Katsuyuki, Hatano, Takaharu, Noda, Satoru, Takashima, Tsutomu, Onoda, Naoyoshi, Tomita, Shuhei, Motomura, Hisashi, Ohsawa, Masahiko, Hirakawa, Kosei, Ohira, Masaichi
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5745786/
https://ncbi.nlm.nih.gov/pubmed/29282021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3927-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires